194 results on '"Srihari, S"'
Search Results
2. Mitral Regurgitation in Obstructive Hypertrophic Cardiomyopathy
3. Coronary Microvascular Dysfunction
4. Treatment Strategies for Hypertrophic Cardiomyopathy: Alcohol Septal Ablation and Procedural Step-by-Step Technique
5. Clinical Outcomes, Resource Utilization, and Treatment Over the Disease Course of Symptomatic Obstructive Hypertrophic Cardiomyopathy in the United States
6. Ultrasound Guidance for Vascular Access for Coronary Angiogram: A Meta-Analysis of Randomized Controlled Trials
7. Medical Therapies to Improve Left Ventricular Outflow Obstruction and Diastolic Function in Hypertrophic Cardiomyopathy
8. Outcomes in non-ST-segment elevation myocardial infarction complicated by in-hospital cardiac arrest based on management strategy
9. Restrictive Covenants and Noncompete Clauses for Physicians
10. A 'Grave' Case of Mitral Regurgitation
11. Intra-Aortic Balloon Pump: Uncovering Myths and Misconceptions
12. Immunotherapy: RAPID ACCESS TO VIRUS-SPECIFIC T CELLS FOR ADOPTIVE IMMUNOTHERAPY FOR COMPASSIONATE USE IN AUSTRALIA
13. Immunotherapy: HARNESSING SURFACE EXPRESSION TO DEFINE A UNIQUE MEMORY T CELL SUBSET WITH STEM-LIKE PROPERTIES TO ENHANCE ADOPTIVE T CELL THERAPIES
14. The Effect of Yoga on Cardiovascular Disease Risk Factors: A Meta-Analysis
15. Exercise and cardiovascular health: A state-of-the-art review
16. Impact of COVID-19 on Outcomes of Patients Hospitalized With STEMI: A Nationwide Propensity-matched Analysis
17. Clinical Outcomes, Resource Utilization, and Treatment Over the Disease Course of Symptomatic Obstructive Hypertrophic Cardiomyopathy in the United States
18. META-ANALYSIS OF PATENT FORAMEN OVALE CLOSURE FOR CRYPTOGENIC STROKE IN OLDER VERSUS YOUNGER PATIENTS
19. IMPROVEMENT IN MULTI-DOMAIN PATIENT-REPORTED OUTCOME SCORES WITH MAVACAMTEN TREATMENT IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: INSIGHTS FROM THE VALOR-HCM STUDY
20. OUTCOMES OF PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY AND PULMONARY HYPERTENSION UNDERGOING SEPTAL REDUCTION THERAPY STRATIFIED BY TREATMENT MODALITY
21. IMPACT OF PULMONARY HYPERTENSION ON SEPTAL REDUCTION THERAPY OUTCOMES FOR HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
22. Effect of COVID-19 Infection in Patients Who Present With Acute Myocardial Infarction and Cardiogenic Shock
23. SLEEP DURATION, MORTALITY AND STROKE AMONG ASIAN POPULATIONS: A META-ANALYSIS
24. FEASIBILITY OF TRANSCATHETER EDGE TO EDGE REPAIR IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
25. Exercise and cardiovascular health: A state-of-the-art review
26. Effect of COVID-19 Infection in Patients Who Present With Acute Myocardial Infarction and Cardiogenic Shock
27. Meta-analysis of Per-Day Step Count and All-Cause Mortality
28. Revascularization of Left Main Coronary Artery in Patients With Diabetes: Is the Pendulum Swinging to PCI?
29. A Meta-Analysis of Traditional Radial Access and Distal Radial Access in Transradial Access for Percutaneous Coronary Procedures
30. Adopting Best Practices in the Management of Coronary Calcification
31. Meta-Analysis of Brief Dual-Antiplatelet Therapy Duration After Percutaneous Coronary Intervention
32. Study design and rationale of VALOR-HCM: evaluation of mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy who are eligible for septal reduction therapy
33. Key Concepts Surrounding Cardiogenic Shock
34. Meta-analysis of Per-Day Step Count and All-Cause Mortality
35. A “Grave” Case of Mitral Regurgitation
36. Meta-Analysis of Brief Dual-Antiplatelet Therapy Duration After Percutaneous Coronary Intervention
37. Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy
38. Impact of Body Mass Index on Mortality in Hospitalized Patients With Hypertrophic Cardiomyopathy
39. Strength training and cardiovascular health: A meta-analysis
40. Intra-Aortic Balloon Pump: Uncovering Myths and Misconceptions
41. The Effect of Yoga on Cardiovascular Disease Risk Factors: A Meta-Analysis
42. Impact of COVID-19 on Outcomes of Patients Hospitalized With STEMI: A Nationwide Propensity-matched Analysis
43. FEASIBILITY OF TRANSCATHETER EDGE TO EDGE REPAIR IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
44. IMPROVEMENT IN MULTI-DOMAIN PATIENT-REPORTED OUTCOME SCORES WITH MAVACAMTEN TREATMENT IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: INSIGHTS FROM THE VALOR-HCM STUDY
45. OUTCOMES OF PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY AND PULMONARY HYPERTENSION UNDERGOING SEPTAL REDUCTION THERAPY STRATIFIED BY TREATMENT MODALITY
46. IMPACT OF PULMONARY HYPERTENSION ON SEPTAL REDUCTION THERAPY OUTCOMES FOR HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
47. SLEEP DURATION, MORTALITY AND STROKE AMONG ASIAN POPULATIONS: A META-ANALYSIS
48. META-ANALYSIS OF PATENT FORAMEN OVALE CLOSURE FOR CRYPTOGENIC STROKE IN OLDER VERSUS YOUNGER PATIENTS
49. Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock.
50. QUALITY AND OUTCOMES OF STEMI CARE IN MIDDLE INCOME COUNTRIES COMPARED TO HIGH INCOME COUTNRIES A META-ANALYSIS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.